The aim of this study was to prospectively evaluate a 2-dimensional real-time CINE TrueFISP magnetic resonance sequence using sparse data sampling with iterative reconstruction (SSIR) for right ventricular (RV) volumetry in comparison to the criterion standard (CS) acquired at 3 T.Ten healthy controls and 20 consecutive patients scheduled for cardiac magnetic resonance imaging on a 3-T system (Magnetom Skyra; Siemens Healthcare Sector, Germany) underwent undersampled SSIR sequences with a single breath-hold (BH) as well as with shallow free breathing (NBH) and a fully sampled multi-BH sequence as CS. Right ventricular volumetry was performed with dedicated cardiac magnetic resonance software (cvi42; Circle Cardiovascular Imaging Inc, Calgary, Alberta, Canada). Agreement of SSIR with and without BH and CS for RV functional parameters (end-systolic volume [RVESV], end-diastolic volume [RVEDV], stroke volume [RVSV], and ejection fraction [RVEF]) were assessed with Bland-Altman analysis and paired t test.Analysis of the 30 individuals (19 male; 48 ± 14 years) revealed no significant differences when comparing CS and BH measurements for RVEDV (153.7 vs 153.6 mL, P = 0.96), RVESV (71.6 vs 72.1 mL, P = 0.78), RVSV (82.0 vs 81.6 mL, P = 0.65), and RVEF (54.9% vs 54.2%, P = 0.19). Similar results were shown when comparing CS and NBH measurements for RVEDV (153.7 vs 152.2 mL, P = 0.34), RVESV (71.6 vs 72.8 mL, P = 0.30), RVSV (82.0 vs 81.0 mL, P = 0.46), and RVEF (54.9 vs 54.4, P = 0.48). Time taken for acquisition was 350 seconds for the CS, 34 seconds for BH, and 25 seconds for NBH measurements. Additional time required for iterative reconstruction was 2 minutes and 30 seconds for the sparse sampled data sets.Our results demonstrate that accurate RV volumetry with SSIR data at 3 T is feasible in clinical routine within 25 seconds even without BH, which is of particular importance in patients with dyspnea.
Poster: ECR 2015 / C-0583 / Accuracy of cardiac MRI single-breath-hold vs non-breath-hold compressed sensing input data for left ventricular volumetry: a clinical feasibility study by: Sudarski, H. Haubenreisser, C. Dosch, S. Haneder, T. Henzler, S. O. Schonberg, T. Pappavassiliu; Mannheim/DE
The reliable exclusion of a pulmonary embolism (PE) in hemodynamically stable patients remains a challenge. The European Society of Cardiology guidelines for PE diagnosis published in 2008 and updated in 2014 recommend a low-threshold computed tomography (CT) indication for patients with a high probability of pulmonary embolism or those with elevated levels of D-dimers. Certain elements of the recommendations are controversial, while others, including the evaluation of the risk factors for PE, are considered only in individual cases. In the present study, various risk factors, including obesity, smoking, contraceptive use, immobility level, history of malignant disease and thrombophilia and the factors of familial predisposition, deep vein thrombosis (DVT)/PE-history, long-distance flying <1 week and surgery <4 weeks previously, were retrospectively examined in 492 patients with a suspected PE. The data demonstrated a significant risk of PE with contraceptive use, a history of DVT/PE and thrombophilia. The immobility level, surgery <4 weeks and long-distance flying <1 week previously, as well as family history, malignant disease, obesity and smoking, were not observed to be associated with a significantly higher risk of PE. Contraceptive use and thrombophilia, in addition to a history of DVT/PE, each appear to have a significant predictive value in the context of PE risk stratification. Therefore, patients with a suspected PE, who additionally present with at least one of the aforementioned risk factors, should undergo further diagnostic steps for PE risk stratification, including a low-threshold CT examination, even in the absence of elevated D-dimers.
Patients after curative treatment of non-small cell lung cancer (NSCLC) have a high risk of loco-regional and/or distant tumor recurrence, especially within the first two years. Timely and accurate detection of recurrence is crucial in order to start salvage or palliative therapies with the overall goal of increasing patients' survival and quality of life. However, with the emerging use of non-surgical curative-intended therapies, follow-up of patients becomes even more challenging, as local recurrence has to be distinguished from various post-therapeutic changes at the site of the primary cancer. Integrated positron emission tomography/computed tomography (PET/CT), which is already an established imaging modality in the staging of NSCLC, is increasingly used in recurrence surveillance algorithms. By detailed morphological information being combined with additional information about the metabolic activity of suspicious sites, determination of suspicious lesions as benign or malignant can be improved. This article reviews the value of integrated PET/CT in assessing recurrence in NSCLC patients after potentially curative surgery and after curative-intended non-surgical therapies and raises as well the issue of cost-effectiveness of PET/CT for follow-up.
Abstract To generate a patient-friendly, time-efficient cardiac MRI examination protocol, a highly accelerated real-time CINE MR sequence (SSIR) was acquired in the idle time in between contrast injection and late gadolinium enhancement phase. 20 consecutive patients underwent a cardiac MRI examination including a multi-breath-hold sequence as gold standard (Ref) as well as SSIR sequences with (SSIR-BH) and without breath-hold (SSIR-nonBH). SSIR sequences were acquired 4 minutes after gadolinium injection. Right- (RV) and left-ventricular (LV) volumetric functional parameters were evaluated and compared between Ref and SSIR sequences. Despite reduced contrast between myocardium and intra-ventricular blood, volumetric as well as regional wall movement assessment revealed high agreement between both SSIR sequences and Ref. Excellent correlation and narrow limits of agreements were found for both SSIR-BH and SSIR-nonBH when compared to Ref for both LV (mean LV ejection fraction [EF] Ref: 52.8 ± 12.6%, SSIR-BH 52.3 ± 12.9%, SSIR-nonBH 52.5 ± 12.6%) and RV (mean RV EF Ref: 52.7 ± 9.4%, SSIR-BH 52.0 ± 8.1%, SSIR-nonBH 52.2 ± 9.3%) analyses. Even when acquired in the idle time in between gadolinium injection and LGE acquisition, the highly accelerated SSIR sequence delivers accurate volumetric and regional wall movement information. It thus seems ideal for very time-efficient and robust cardiac MR imaging protocols.
